• Users Online: 286
  • Print this page
  • Email this page
Year : 2020  |  Volume : 8  |  Issue : 1  |  Page : 27-28

Management of autoimmune ear disease and idiopathic polyarthritis with adalimumab

1 Consultant Rheumatologist, Apollo Hospital, Mysore, Karnataka, India
2 Consultant ENT Surgeon, Neha ENT Centre, Ramanuja Road, Mysore, Karnataka, India
3 Medical Advisor, Zydus Cadila Health Care Ltd., Ahmedabad, Gujarat, India

Correspondence Address:
Dr. Shiva Prasad
Apollo Hospital, Mysore, Karnataka
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/AJIM.AJIM_29_19

Rights and Permissions

Autoimmune inner ear disease (AIED) is a rare form of sensorineural hearing loss of autoimmune origin and responding to immunosuppressive therapy with corticosteroids or other immunosuppressants. Novel treatment approaches include intratympanic steroids and biological response modulators against tumor necrosis factor-α. We present a case of AIED, who concomitantly developed seronegative inflammatory polyarthritis (IPA). The treatment for IPA was initiated with methotrexate, hydroxychloroquine, and intra-articular methyl prednisolone. When there was no adequate response, the patient was started on adalimumab, which in addition to IPA also showed beneficial effects on AIED.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded36    
    Comments [Add]    

Recommend this journal